U.S. flag

An official website of the United States government

NM_000212.3(ITGB3):c.557C>T (p.Pro186Leu) AND Glanzmann thrombasthenia

Germline classification:
Likely benign (1 submission)
Last evaluated:
Feb 8, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003222153.2

Allele description [Variation Report for NM_000212.3(ITGB3):c.557C>T (p.Pro186Leu)]

NM_000212.3(ITGB3):c.557C>T (p.Pro186Leu)

Gene:
ITGB3:integrin subunit beta 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_000212.3(ITGB3):c.557C>T (p.Pro186Leu)
Other names:
NM_000212.3(ITGB3):c.557C>T; p.Pro186Leu
HGVS:
  • NC_000017.11:g.47284638C>T
  • NG_008332.2:g.35797C>T
  • NM_000212.3:c.557C>TMANE SELECT
  • NP_000203.2:p.Pro186Leu
  • LRG_481t1:c.557C>T
  • LRG_481:g.35797C>T
  • NC_000017.10:g.45362004C>T
  • NC_000017.10:g.45362004C>T
  • NM_000212.2:c.557C>T
Protein change:
P186L
Links:
dbSNP: rs61736876
NCBI 1000 Genomes Browser:
rs61736876
Molecular consequence:
  • NM_000212.3:c.557C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glanzmann thrombasthenia
Synonyms:
PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY; Thrombasthenia of Glanzmann and Naegeli; Glanzmann thrombasthenia type A; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0100326; MedGen: C0040015; Orphanet: 849; OMIM: PS273800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003915975ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen Platelet ACMG Specifications v2-1)
Likely benign
(Feb 8, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen, SCV003915975.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.557C>T variant in ITGB3 is a missense variant predicted to cause substitution of proline by leucine at amino acid 186. The variant has a high population minor allele frequency in gnomAD v2.1.1 of 0.007131 (178/24960) in the African/African American population, which is higher than the ClinGen PD VCEP threshold (>0.0024). The computational predictor REVEL gives a score of 0.733, which is above the ClinGen PD VCEP PP3 threshold of >0.7 and predicts a damaging effect on ITGB3 function. It is reported to have an association with lower platelet count in an African American cohorts (PMID: 23103231) but has not been reported in a Glanzmann thrombasthenia patient to our knowledge. In summary, this variant meets the criteria to be classified as a variant of unknown significance - conflicting evidence for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1, PP3. (VCEP specifications version 2; date of approval 2/2/2023)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024